Literature DB >> 22555527

Body mass index and outcome of ASC-H-interpreted cervical smears in postmenopausal women.

Soomin Ahn1, Yoo-Young Lee, Ji-Youn Sung, Jae Jun Lee, Young Lyun Oh, Chang Ohk Sung, Sang Yong Song.   

Abstract

OBJECTIVE: Patient age is one important factor used to evaluate the risk in women with ASC-H (atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion). This finding may be associated with atrophic changes reflecting a hypoestrogenic status and suggests that body mass index (BMI) can affect the outcome of ASC-H smears in postmenopausal women. STUDY
DESIGN: We investigated the outcome of 154 postmenopausal women with an ASC-H smear and assessed relationships with BMI categories and serum estradiol levels.
RESULTS: In patients with higher BMI, an underlying squamous intraepithelial lesion (SIL) was more frequent than in patients with lower BMI, and a higher BMI was also associated with increased serum estradiol levels. When samples were classified by preparation method, these findings were more pronounced in liquid-based smears than in conventional smears. Principal component analysis using three factors (BMI, age and human papilloma virus status) revealed two distinct groups: those with a negative cervical smear and those with a smear result indicating SIL+.
CONCLUSION: Hormonal alterations can affect the outcome of ASC-H smears, and BMI is one factor that should be considered when evaluating the risk associated with ASC-H smears in postmenopausal women.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555527     DOI: 10.1159/000337448

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  1 in total

1.  Histopathology of Women with “Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion”zzm321990(ASC-H) Smears

Authors:  Sasivimon Ratree; Pilaiwan Kleebkaow; Apiwat Aue-Aungkul; Amornrat Temtanakitpaisan; Bandit Chumworathayi; Sanguanchoke Luanratanakorn
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.